
Privi Speciality (PRIVISCL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
5.6B
Gross Profit
2.8B
50.74%
Operating Income
958.6M
17.15%
Net Income
575.5M
10.30%
EPS (Diluted)
₹15.85
Balance Sheet Metrics
Total Assets
27.9B
Total Liabilities
16.7B
Shareholders Equity
11.2B
Debt to Equity
1.50
Cash Flow Metrics
Revenue & Profitability Trend
Privi Speciality Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 20.9B | 17.5B | 16.1B | 14.0B | 12.7B |
Cost of Goods Sold | 11.9B | 10.6B | 10.1B | 8.7B | 7.9B |
Gross Profit | 9.0B | 7.0B | 6.0B | 5.3B | 4.8B |
Gross Margin % | 43.2% | 39.7% | 37.3% | 37.9% | 37.6% |
Operating Expenses | |||||
Research & Development | 13.2M | 20.3M | 53.7M | 65.2M | 61.5M |
Selling, General & Administrative | 1.5B | 965.0M | 1.2B | 1.0B | 788.3M |
Other Operating Expenses | 2.1B | 1.8B | 2.0B | 1.4B | 1.1B |
Total Operating Expenses | 3.6B | 2.8B | 3.2B | 2.5B | 1.9B |
Operating Income | 3.3B | 2.1B | 798.2M | 1.2B | 1.4B |
Operating Margin % | 15.6% | 11.7% | 5.0% | 8.6% | 11.0% |
Non-Operating Items | |||||
Interest Income | 38.7M | 3.2M | 2.8M | 3.0M | 4.8M |
Interest Expense | 878.8M | 979.4M | 678.1M | 241.1M | 214.1M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 2.5B | 1.3B | 310.4M | 1.3B | 1.6B |
Income Tax | 697.7M | 344.8M | 97.7M | 353.7M | 413.2M |
Effective Tax Rate % | 27.4% | 26.5% | 31.5% | 26.6% | 26.1% |
Net Income | 1.8B | 954.3M | 212.8M | 973.8M | 1.2B |
Net Margin % | 8.8% | 5.4% | 1.3% | 6.9% | 9.2% |
Key Metrics | |||||
EBITDA | 4.7B | 3.5B | 2.1B | 2.3B | 2.3B |
EPS (Basic) | ₹47.87 | ₹24.43 | ₹5.45 | ₹24.93 | ₹29.93 |
EPS (Diluted) | ₹47.87 | ₹24.43 | ₹5.45 | ₹24.93 | ₹29.93 |
Basic Shares Outstanding | 39062706 | 39062706 | 39062706 | 39062700 | 39062700 |
Diluted Shares Outstanding | 39062706 | 39062706 | 39062706 | 39062700 | 39062700 |
Income Statement Trend
Privi Speciality Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 496.7M | 239.9M | 204.5M | 325.2M | 154.5M |
Short-term Investments | 75.4M | 395.6M | 67.3M | 120.0M | 123.8M |
Accounts Receivable | 3.9B | 3.5B | 3.0B | 2.6B | 2.4B |
Inventory | 7.9B | 6.6B | 8.0B | 6.2B | 3.4B |
Other Current Assets | 1.2B | 666.0M | 755.4M | 1.1B | 907.6M |
Total Current Assets | 13.6B | 11.4B | 12.0B | 10.5B | 7.0B |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.3B | 1.1B | 962.4M | 604.5M | 487.2M |
Goodwill | 245.1M | 200.6M | 161.5M | 146.2M | 72.7M |
Intangible Assets | 245.1M | 200.6M | 161.5M | 146.2M | 72.7M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 594.1M | 240.7M | 318.6M | 5.4M | 451.8M |
Total Non-Current Assets | 14.3B | 12.0B | 11.9B | 11.2B | 8.4B |
Total Assets | 27.9B | 23.4B | 23.9B | 21.8B | 15.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 4.0B | 2.8B | 2.9B | 3.1B | 1.7B |
Short-term Debt | 6.2B | 5.5B | 6.6B | 5.4B | 2.0B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 42.1M | 53.3M | 32.4M | 38.1M | 25.9M |
Total Current Liabilities | 11.0B | 9.0B | 11.0B | 9.3B | 4.5B |
Non-Current Liabilities | |||||
Long-term Debt | 5.2B | 4.6B | 4.2B | 4.0B | 3.4B |
Deferred Tax Liabilities | 241.1M | 232.0M | 198.4M | 132.5M | 132.6M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 5.7B | 5.1B | 4.5B | 4.3B | 3.6B |
Total Liabilities | 16.7B | 14.0B | 15.6B | 13.6B | 8.2B |
Equity | |||||
Common Stock | 390.6M | 390.6M | 390.6M | 390.6M | 390.6M |
Retained Earnings | 7.0B | 5.3B | 4.3B | 4.2B | 3.3B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 11.2B | 9.4B | 8.4B | 8.2B | 7.2B |
Key Metrics | |||||
Total Debt | 11.4B | 10.1B | 10.8B | 9.3B | 5.4B |
Working Capital | 2.6B | 2.5B | 1.0B | 1.2B | 2.5B |
Balance Sheet Composition
Privi Speciality Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 2.5B | 1.3B | 310.4M | 1.3B | 1.6B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -2.6B | 521.5M | -1.4B | -3.3B | -701.1M |
Operating Cash Flow | 817.0M | 2.8B | -436.0M | -1.8B | 1.1B |
Investing Activities | |||||
Capital Expenditures | -3.0B | -1.4B | -1.4B | -3.1B | -2.4B |
Acquisitions | 320.2M | -50.0M | 0 | -120.0M | 0 |
Investment Purchases | -327.8M | -334.2M | -1.6M | -2.7M | -2.7M |
Investment Sales | 33.9M | 730.0K | 63.1M | 0 | 10.5M |
Investing Cash Flow | -3.0B | -1.8B | -1.3B | -3.2B | -2.4B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -78.1M | - | -78.1M | -78.1M | -58.6M |
Debt Issuance | 3.1B | 2.4B | 1.2B | 1.1B | 1.4B |
Debt Repayment | -2.5B | -1.6B | -606.8M | -337.3M | -209.9M |
Financing Cash Flow | 1.3B | -691.0M | 1.4B | 3.7B | 472.6M |
Free Cash Flow | -180.3M | 2.0B | -909.3M | -3.0B | -934.9M |
Net Change in Cash | -800.7M | 299.2M | -351.2M | -1.3B | -857.1M |
Cash Flow Trend
Privi Speciality Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
43.87
Price to Book
8.65
Price to Sales
4.35
PEG Ratio
0.46
Profitability Ratios
Profit Margin
9.91%
Operating Margin
17.15%
Return on Equity
16.73%
Return on Assets
6.70%
Financial Health
Current Ratio
1.24
Debt to Equity
104.22
Beta
-0.40
Per Share Data
EPS (TTM)
₹55.68
Book Value per Share
₹282.48
Revenue per Share
₹561.81
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
priviscl | 95.4B | 43.87 | 8.65 | 16.73% | 9.91% | 104.22 |
Asian Paints | 2.4T | 65.93 | 12.25 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.77 | 16.03 | 20.85% | 16.16% | 4.56 |
BASF India | 199.7B | 50.39 | 5.49 | 13.18% | 2.61% | 5.23 |
Atul | 189.9B | 37.95 | 3.39 | 8.55% | 8.71% | 3.56 |
Kansai Nerolac | 188.0B | 16.61 | 2.93 | 17.85% | 14.43% | 4.63 |
Financial data is updated regularly. All figures are in the company's reporting currency.